- $3.00bn
- $3.32bn
- $1.15bn
- 67
- 29
- 89
- 64
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,084 | 934 | 1,035 | 1,022 | 1,154 |
Cost of Revenue | |||||
Gross Profit | 724 | 595 | 706 | 707 | 771 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,256 | 1,210 | 1,096 | 1,099 | 1,222 |
Operating Profit | -172 | -275 | -61 | -76.8 | -68.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -188 | -348 | -124 | -75.1 | -81.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -158 | -347 | -136 | -86.2 | 17.6 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -158 | -349 | -136 | -86.2 | 17.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -158 | -349 | -136 | -86.2 | 17.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.17 | -4.19 | -1.3 | 0.312 | 1.83 |